Zoetis Acquires Basepaws to Expand Precision Petcare Genetics and Diagnostics

June 7, 2022

Zoetis agreed to acquire Basepaws, a privately held petcare genetics company that provides genetic tests, analytics, and early health risk assessments for pets. Zoetis said the deal will strengthen its precision animal health portfolio and inform its future petcare R&D pipeline using Basepaws’ feline genomic and microbiome database.

Buyers
Zoetis Inc.
Targets
Basepaws
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.